Viewing stories from November, 2014

Marketing Clearance for VivaGel® condom in New Zealand

Starpharma today announced the completion of the regulatory requirements to allow for marketing of the VivaGel® condom in New Zealand under the brand Lifestyles® Dual Protect™.

Starpharma’s Priostar® Glyphosate Patent Allowed in China

Starpharma today announced that the State Intellectual Property Office of China has agreed to grant a formulation patent for Priostar® dendrimers with agrochemicals, including with glyphosate. This will further strengthen and expand Starpharma’s patent portfolio for the use of its proprietary dendrimers in agrochemical products.

This website is intended for people seeking information about Starpharma for investment and business purposes. This website contains information about products that may not be available, or approved, in all countries, or may be available under different trademarks, or for different indications. Individuals seeking information about a Starpharma product should visit the relevant product website in their country of residence or consult a healthcare provider. Nothing contained on this site should be considered a solicitation, promotion, or advertisement for any product, including those under development. Any information on this site is not intended to provide medical advice nor should be used as a substitute for the advice provided by a doctor or other healthcare provider.